FDA re-examines safety of Parkinson's drug suspected in hundreds of deaths

The Food and Drug Administration says it is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks.

Comments

Popular posts from this blog

Canadian transit agency teases amazing new transportation technology: the bus

Amazon’s plans for a New York office are under new scrutiny

Why Twitter should ignore the phony outrage over “shadow banning”